Overview of genetic signaling pathway interactions within cutaneous malignancies

Abstract

Melanoma and non-melanoma cutaneous malignancies are some of the leading causes of cancer-related death in the United States. Though melanoma is more known to have a high mortality rate, the total mortality per year is nearly equal for between melanoma and non-melanoma skin cancer. Moreover, the non-melanoma types of cutaneous malignancies have potential to become locally invasive and even metastasize with very little to no treatment options when advanced. The development of these malignancies involves various genetic pathways through the four hallmarks of cancer development: malignant cell growth, apoptosis evasion, the use of supporting stroma and vascularization, and modulating and promoting an inadequate immune response. The genetic signaling pathways of basal cell carcinoma, squamous cell carcinoma, verrucous carcinoma, basosquamous cell carcinoma, melanoma, and cutaneous T-cell lymphoma interact with each other through genetic predisposition as well as with environmental exposures. Furthermore, solar ultraviolet radiation and chronic inflammatory states are found to initiate the progression of many of these cutaneous malignancies. This paper includes validated models of genetic pathways, emerging pathways, and crosstalk between genetic pathways through the four hallmarks of cancer development. Moreover, unlike most reviews addressing oncogenetics of the well-recognized, as well as newly discovered, genetic pathway mutations, this review stresses that these pathways are not fixed but rather exist in dynamic, interrelated, interactive, complex, and adaptive flux states.

Keywords

Basal cell carcinoma / squamous cell carcinoma / verrucous carcinoma / basosquamous cell carcinoma / melanoma / cutaneous T-cell lymphoma / genetic pathways / cancer hallmarks

References

[1] Ley RD.Photoreactivation in humans..Proc Natl Acad Sci U S A1993;90:4337 PMCID:PMC46505

[2] Feehan RP.Molecular signaling cascades involved in nonmelanoma skin carcinogenesis..Biochem J2016;473:2973-94 PMCID:PMC5198714

[3] Sample A.Mechanisms and prevention of UV-induced melanoma..Photodermatol Photoimmunol Photomed2018;34:13-24 PMCID:PMC5760354

[4] de Gruijl FR.Photocarcinogenesis: UVA vs. UVB radiation..Skin Pharmacol Appl Skin Physiol2002;15:316-20

[5] Craig S,Virós A.Ultraviolet light and melanoma..J Pathol2018;244:578-85

[6] Patrick MH.Studies on thymine-derived UV photoproducts in DNA--I. Formation and biological role of pyrimidine adducts in DNA..Photochem Photobiol1977;25:357-72

[7] Lee JH,Karin M.Sestrins orchestrate cellular metabolism to attenuate aging..Cell Metabolism2013;18:792-801 PMCID:PMC3858445

[8] Budanov AV.p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling..Cell2008;134:451-60 PMCID:PMC2758522

[9] Holick MF.Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health..Anticancer Res2016;36:1345-56

[10] Leavitt E,Martin S.Sonic hedgehog pathway inhibition in the treatment of advanced basal cell carcinoma..Curr Treat Options Oncol2019;20:84

[11] Bolognia JJ,Rapini RP.Dermatology.2012;PhiladelphiaElsevier Saunders

[12] Xie J,Luoh SM,Gu Q.Activating smoothened mutations in sporadic basal-cell carcinoma..Nature1998;391:90-2

[13] Marzuka AG.Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management..Yale J Biol Med2015;88:167-79 PMCID:PMC4445438

[14] Gutzmer R.Hedgehog pathway inhibition for the treatment of basal cell carcinoma..Target Oncol2019;14:253-67

[15] Pala R,Nauli SM.Primary cilium-dependent signaling mechanisms..Int J Mol Sci2017;18:2272 PMCID:PMC5713242

[16] Hutchin ME,Grachtchouk M,Wei L.Sustained hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle..Genes Dev2005;19:214-23 PMCID:PMC545881

[17] Pontén F,Ahmadian A,Nistér M.Molecular pathology in basal cell cancer with p53 as a genetic marker..Oncogene1997;15:1059-67

[18] Sekulic A,Oro AE,Lewis KD.Efficacy and safety of vismodegib in advanced basal-cell carcinoma..N Engl J Med2012;366:2171-9 PMCID:PMC5278761

[19] Kong JH,Rohatgi R.Biochemical mechanisms of vertebrate hedgehog signaling..Development (Cambridge, England)2019;146:dev166892 PMCID:PMC6550017

[20] Bakkenist CJ.DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation..Nature2003;421:499-506

[21] Jazayeri A,Lukas C,Smith GC.ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks..Nat Cell Biol2006;8:37-45

[22] Shen T.The role of Cdc25A in the regulation of cell proliferation and apoptosis..Anticancer Agents Med Chem2012;12:631-9 PMCID:PMC3544488

[23] Decraene D,Pupe A,Garmyn M.Acute response of human skin to solar radiation: regulation and function of the p53 protein..J Photochem Photobiol B2001;63:78-83

[24] Liu P,Chin YR,Guo J.PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex..Cancer Discov2015;5:1194-209 PMCID:PMC4631654

[25] Zhang Y.Roles of Chk1 in cell biology and cancer therapy..Int J Cancer2014;134:1013-23 PMCID:PMC3852170

[26] Xiong Y,Zhang H,Kobayashi R.p21 is a universal inhibitor of cyclin kinases..Nature1993;366:701-4

[27] Rezvani HR,Cario-André M,Ged C.Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes..J Biol Chem2006;281:17999-8007

[28] Sander CS,Elsner P.Oxidative stress in malignant melanoma and non-melanoma skin cancer..Br J Dermatol2003;148:913-22

[29] Zhang J.Activation of p38 MAP kinase and JNK pathways by UVA irradiation..Photochem Photobiol Sci2012;11:54-61 PMCID:PMC4041221

[30] Nadeau PJ,Toledano MB.Disulfide bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis..Mol Biol Cell2007;18:3903-13 PMCID:PMC1995733

[31] Gross S,Tenev T,Gaestel M.Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction..J Biol Chem1999;274:26378-86

[32] Reinhardt HC,Lees JA.p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage..Cancer Cell2007;11:175-89 PMCID:PMC2742175

[33] Hess J,Schorpp-Kistner M.AP-1 subunits: quarrel and harmony among siblings..J Cell Sci2004;117:5965-73

[34] Silvers AL,Bowden GT.Inhibition of UVA-induced c-Jun N-terminal kinase activity results in caspase-dependent apoptosis in human keratinocytes..Photochem Photobiol2006;82:423-31

[35] Cooper SJ,Ranger-Moore J,Colburn NH.Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model..Mol Cancer Res2003;1:848-54

[36] Strozyk E.The role of AKT/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence..Int J Mol Sci2013;14:15260-85 PMCID:PMC3759859

[37] Coffer PJ,Peppelenbosch MP,Kruijer W.UV activation of receptor tyrosine kinase activity..Oncogene1995;11:561-9

[38] Arora A.Role of tyrosine kinase inhibitors in cancer therapy..J Pharmacol Exp Ther2005;315:971-9

[39] Spallone G,Costanzo A.Targeted therapy in nonmelanoma skin cancers..Cancers (Basel)2011;3:2255-73 PMCID:PMC3757416

[40] Laplante M.mTOR signaling in growth control and disease..Cell2012;149:274-93 PMCID:PMC3331679

[41] Hafner C,Vogt T.Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations..Exp Dermatol2010;19:e222-7

[42] Ming M.PTEN: new insights into its regulation and function in skin cancer..J Invest Dermatol2009;129:2109-12 PMCID:PMC2758921

[43] Hemmings BA.PI3K-PKB/Akt pathway..Cold Spring Harb Perspect Biol2012;4:a011189 PMCID:PMC3428770

[44] Shimobayashi M.Making new contacts: the mTOR network in metabolism and signalling crosstalk..Nat Rev Mol Cell Biol2014;15:155-62

[45] Gan X,Su B.Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate..J Biol Chem2011;286:10998-1002 PMCID:PMC3064154

[46] Tu Y,Yang B,Gu H.DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival..Mol Cancer2013;12:172 PMCID:PMC3922905

[47] Greer EL.FOXO transcription factors at the interface between longevity and tumor suppression..Oncogene2005;24:7410-25

[48] Daitoku H.FOXO transcription factors in the regulatory networks of longevity..J Biochem2007;141:769-74

[49] Bivik C.JNK mediates UVB-induced apoptosis upstream lysosomal membrane permeabilization and Bcl-2 family proteins..Apoptosis2008;13:1111-20

[50] Qin JZ,Panella J,Denning MF.Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis..J Cell Physiol2004;200:155-66

[51] Kim DJ,Sano S,Kiguchi K.Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis..Mol Carcinog2009;48:873-85 PMCID:PMC4066197

[52] Obsil T,Anderson DE,Dyda F.Two 14-3-3 binding motifs are required for stable association of Forkhead transcription factor FOXO4 with 14-3-3 proteins and inhibition of DNA binding..Biochemistry2003;42:15264-72

[53] Dhanasekaran DN.JNK signaling in apoptosis..Oncogene2008;27:6245-51 PMCID:PMC3063296

[54] Wellbrock C,Marais R.The RAF proteins take centre stage..Nat Rev Mol Cell Biol2004;5:875-85

[55] McCubrey JA,Chappell WH,Wong EW.Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance..Biochim Biophys Acta2007;1773:1263-84 PMCID:PMC2696318

[56] Omran OM.Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer..Am J Dermatopathol2014;36:710-7

[57] Shimizu T,Papadopoulos KP,Rasco DW.The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer..Clin Cancer Res2012;18:2316-25

[58] Paul G,McCole DF.Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport..J Biol Chem2012;287:2144-55 PMCID:PMC3265893

[59] Chaisuparat R,Kongpanitkul S,Jham BC.The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity..J Oral Pathol Med2016;45:581-5

[60] Kim C.Epidermal p65/NF-κB signalling is essential for skin carcinogenesis..EMBO Mol Med2014;6:970-83 PMCID:PMC4119358

[61] Hoesel B.The complexity of NF-κB signaling in inflammation and cancer..Mol Cancer2013;12:86

[62] Carpenter RL.STAT3 target genes relevant to human cancers..Cancers (Basel)2014;6:897-925 PMCID:PMC4074809

[63] Wilson NS,Ashkenazi A.Death receptor signal transducers: nodes of coordination in immune signaling networks..Nat Immunol2009;10:348-55

[64] Gordon R.Skin cancer: an overview of epidemiology and risk factors..Semin Oncol Nurs2013;29:160-9

[65] Burton KA,Khachemoune A.Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease..Am J Clin Dermatol2016;17:491-508

[66] Immunotherapy drug cemiplimab approved for advanced squamous cell skin cancer. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2018/cemiplimab-fda-squamous-cell-carcinoma. [Last accessed on 7 Sep 2020]

[67] Benjamin CL.p53 and the pathogenesis of skin cancer..Toxicol Appl Pharmacol2007;224:241-8 PMCID:PMC2080850

[68] Kang D,Han K,Kim JH.Regulation of K(+) channels may enhance wound healing in the skin..Med Hypotheses2008;71:927-9

[69] Liu Q,Zhao W,Chu Q.EGFR-TKIs resistance via EGFR-independent signaling pathways..Mol Cancer2018;17:53 PMCID:PMC5817859

[70] Wenczak BA,Nanney LB.Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair..J Clin Invest1992;90:2392-401 PMCID:PMC443395

[71] Heo JS,Han HJ.Sonic hedgehog stimulates mouse embryonic stem cell proliferation by cooperation of Ca2+/protein kinase C and epidermal growth factor receptor as well as Gli1 activation..Stem Cells2007;25:3069-80

[72] Carballo GB,de Lopes GPF.A highlight on Sonic hedgehog pathway..Cell Communication and Signaling2018;16:11 PMCID:PMC5861627

[73] Panelos J,Paglierani M,Maio V.Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma..Mod Pathol2008;21:316-25

[74] Yang L, XL, Brooks YS. Dysregulated estrogen signaling through CYP1B1 contributes to notch deficiency in squamous cell carcinoma. Society of investigative dermatology: youtube presentation; 2020. Available from: https://www.youtube.com/watch?v=nxpbcf1xdca. [Last accessed on 7 Sep 2020]

[75] Al Labban D,Ostano P,Bongiovanni M.Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B..J Clin Invest2018;128:2581-99 PMCID:PMC5983322

[76] Konicke K,Muñoz-Carrillo JL,Flores-de la Torre A.The microRNA landscape of cutaneous squamous cell carcinoma..Drug Discov Today2018;23:864-70

[77] Kollias N,Sayre RM.The value of the ratio of UVA to UVB in sunlight..Photochem Photobiol2011;87:1474-5

[78] Mahler V.Skin diseases associated with environmental factors..Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz2017;60:605-17

[79] Agar N.Melanogenesis: a photoprotective response to DNA damage?.Mutat Res2005;571:121-32

[80] Hung KF,Nghiem P.The 6-4 photoproduct is the trigger of UV-induced replication blockage and ATR activation..Proc Natl Acad Sci U S A2020;117:12806-16 PMCID:PMC7293618

[81] Center V-IC.Cell cycle control: overview. Cell Cycle Control.2016;Vanderbilt University

[82] Ra SH,Li X,Cochran AJ.Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective..Mod Pathol2015;28:799-806

[83] Atasoy M,Pirim I,Ikbal M.HLA antigen profile differences in patients with SCC (Squamous Cell Carcinoma) in-situ/actinic keratosis and invasive SCC: is there a genetic succeptibility for invasive SCC development?.Eurasian J Med2009;41:162-4 PMCID:PMC4261280

[84] Berhane T,Cooke B.Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans..Br J Dermatol2002;146:810-5

[85] Maru GB,Ramchandani A.The role of inflammation in skin cancer..Adv Exp Med Biol2014;816:437-69

[86] Yu H,Jove R.STATs in cancer inflammation and immunity: a leading role for STAT3..Nat Rev Cancer2009;9:798-809 PMCID:PMC4856025

[87] Scola N,Wieland U,Gambichler T.Altered gene expression in squamous cell carcinoma arising from congenital unilateral linear porokeratosis..Clin Exp Dermatol2012;37:781-5

[88] Pi J,Sun Y,Qu W.Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2..Free Radic Biol Med2008;45:651-8 PMCID:PMC2658531

[89] Colman JA.Arsenic and uranium in water from private wells completed in bedrock of east-central Massachusetts-Concentrations, correlations with bedrock units, and estimated probability maps..Sci Invest Rep2011;doi: 10.3133/sir20115013

[90] Li C,Elmets CA,Athar M.Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein..Biochem Biophys Res Commun2013;438:607-12

[91] Poulalhon N,Balme B.Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib..Dermatology2015;230:101-4

[92] Nissinen L,Riihilä P.New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma..Cell Tissue Res2016;365:691-702

[93] Zgraggen S,Kerl K.An important role of the SDF-1/CXCR4 axis in chronic skin inflammation..PLoS One2014;9:e93665 PMCID:PMC3973543

[94] Sinha S,Workentine M,Cheng M.Transcriptional analysis reveals evidence of chronically impeded ECM turnover and epithelium-to-mesenchyme transition in scar tissue giving rise to marjolin’s ulcer..J Burn Care Res2017;38:e14-22

[95] Peters FS,Mandaviya PR,Hofland LJ.Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer..Clin Epigenetics2018;10:81 PMCID:PMC6006560

[96] Wysong A,Covington KR,Ibrahim SF.Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma..J Am Acad Dermatol2020;doi: 10.1016/j.jaad.2020.04.088

[97] Costache M,Mitrache LE,Dumitru A.Cutaneous verrucous carcinoma - report of three cases with review of literature..Rom J Morphol Embryol2014;55:383-8

[98] Schell BJ,Rády P,Tschen JA.Verrucous carcinoma of the foot associated with human papillomavirus type 16..J Am Acad Dermatol2001;45:49-55

[99] Murao K,Fukumoto D,Arase S.Verrucous carcinoma of the scalp associated with human papillomavirus type 33..Dermatol Surg2005;31:1363-5

[100] Fujita S,Kumatori A,Ikeda T.Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression..Pathobiology2008;75:257-64

[101] Ren B.E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints..Genes Dev2002;16:245-56 PMCID:PMC155321

[102] Yim EK.The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis..Cancer Res Treat2005;37:319 PMCID:PMC2785934

[103] Pătraşcu V,Ciurea R.Case report acral verrucous carcinoma..Curr Health Sci J2019;45:235-40 PMCID:PMC6778290

[104] Schumann H,Has C,Erfurt-Berge C.Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene..Br J Dermatol2012;167:929-36

[105] Jung H,Ha H.Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity..J Biol Chem2008;283:20383-96

[106] Coulombe PA.Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath..J Invest Dermatol2012;132:763-75 PMCID:PMC3279600

[107] Bolling MC,Jansen GHL.Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients..Br J Dermatol2011;164:637-44

[108] Porta C,Mosca A.Targeting PI3K/Akt/mTOR signaling in cancer..Front Oncol2014;4: PMCID:PMC3995050

[109] Deng Z,Fang X,Pan H.Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma..Cancer Gene Ther2017;24:282-8

[110] Deng Z,Fang X,Pan H.Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma..Cancer Gene Ther2017;24:

[111] Adegboyega PA,Freeman DH.Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma..Appl Immunohistochem Mol Morphol2005;13:171-7

[112] Kusume T,Kawabata M,Umesaki N.The p16-Cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer..Clin Cancer Res1999;5:

[113] Al-Mohanna MA,Al-Mukhalafi Z,Aboussekhra A.The tumor suppressor p16INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin..Oncogene2004;23:201-12

[114] Bruno S.Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells..Cell Proliferation1992;25:31-40

[115] Mallick S,Gupta SD,Mohanty BK.Angiogenesis, proliferative activity and DNA ploidy in oral verrucous carcinoma: a comparative study including verrucous hyperplasia and squamous cell carcinoma..Pathol Oncol Res2015;21:1249-57

[116] Yang G,Liu G,Guo X.CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis..Clin Cancer Res2010;16:3875-86 PMCID:PMC2930833

[117] Coussens LM.Inflammation and cancer..Nature2002;420:860-7 PMCID:PMC6195709

[118] Langowski JL,Wu L,Chen T.IL-23 promotes tumour incidence and growth..Nature2006;442:461-5

[119] Tchernev G,Bevelacqua V.Carcinoma cuniculatum in course of etanercept: blocking autoimmunity but propagation of carcinogenesis?.Int J Immunopathol Pharmacol2014;27:261-6

[120] Chen Y,Yang Y,Liu G.Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses..Clin Rheumatol2016;35:1-18

[121] Garcia C,Crowson AN.Basosquamous carcinoma..J Am Acad Dermatol2009;60:137-43

[122] Basosquamous Cell Cancer. In: Hoffman H, editor. Iowa Head and Neck Protocols:2017;University of Iowa Health Care

[123] Akay BN,Heper AO,Rosendahl C.Basosquamous carcinoma: Dermoscopic clues to diagnosis..J Dermatol2017;44:127-34

[124] Anand RL,Chapman A.Basosquamous carcinoma: appearance and reality..Oxf Med Case Rep2017;2017: PMCID:PMC5209554

[125] Tarapore E.Defining the genetics of basosquamous carcinoma..J Invest Dermatol2019;139:2258-60

[126] Murthaiah P,Shah S.Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features of colonic and lung primary tumors..Anticancer Res2009;29:1495-7

[127] Lara F,Garbers LM.Recurrence rate of basal cell carcinoma with positive histopathological margins and related risk factors..An Bras Dermatol2017;92:58-62 PMCID:PMC5312180

[128] Oldbury J,Abas S,Iyer S.Basosquamous carcinoma: a single centre clinicopathological evaluation and proposal of an evidence-based protocol..J Skin Cancer2018;2018: PMCID:PMC6008864

[129] Piva de Freitas P,Tabai M,Altemani A.Metastatic basal cell carcinoma: a rare manifestation of a common disease..Case Rep Med2017;2017: PMCID:PMC5723960

[130] Major A.Not just skin deep: distant metastases from cutaneous squamous cell carcinoma..Am J Med2017;130:

[131] Alam M.Basal cell carcinoma recurrence after mohs surgery.2012;U.S. National Laboratory of Medicine

[132] Metastatic Squamous Cell Carcinoma. Transplant Skin Cancer Network: University of California San Francisco. Available from: https://skincancer.ucsf.edu/metastatic-squamous-cell-carcinoma. [Last accessed on 7 Sep 2020]

[133] van Lee CB,Wakkee M,Mooyaart AL.Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study..Br J Dermatol2019;181:338-43

[134] Martin RC2nd,Cawte TG,McMasters KM.Basosquamous carcinoma: analysis of prognostic factors influencing recurrence..Cancer2000;88:1365-9

[135] Chiang A,Kuonen F,Chiang F.Genetic mutations underlying phenotypic plasticity in basosquamous carcinoma..J Invest Dermatol2019;139:2263-71.e5 PMCID:PMC6839544

[136] Zhao X,Ornell KJ,Dabral SK.RAS/MAPK activation drives resistance to smo inhibition, metastasis, and tumor evolution in shh pathway-dependent tumors..Cancer Res2015;75:3623-35 PMCID:PMC4558230

[137] Osawa H,Takano K,Mashima H.Sonic hedgehog stimulates the proliferation of rat gastric mucosal cells through ERK activation by elevating intracellular calcium concentration..BiochemBiophys Res Commun2006;344:680-7

[138] Solomon JA,Shutty B.Calcium dependence of the SHH pathway and theoretical implications in oral treatment of locally advanced or metastatic basal cell carcinomas..Cutaneous Oncol Today2011;9-13

[139] Ji J,Mielgo A,Erb P.Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA..Gene Therapy2005;12:678-84

[140] Hardwick JM.Multiple functions of BCL-2 family proteins..Cold Spring Harb Perspect Biol2013;5: PMCID:PMC3552500

[141] N Sivrikoz O.The effects of cyclin D1 and Bcl-2 expressıon on aggressive behavior in basal cell and basosquamous carcinoma..Iran J Pathol2015;10:185-91 PMCID:PMC4539776

[142] Rishikaysh P,Diaz D,Filip S.Signaling involved in hair follicle morphogenesis and development..Int J Mol Sci2014;15:1648-70 PMCID:PMC3907891

[143] Ellis T,Riley E,Adolphe C.Overexpression of sonic hedgehog suppresses embryonic hair follicle morphogenesis..Dev Biol2003;263:203-15

[144] Kasper M,Are A,Schwäger A.Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes..Proc Nat Acad Sci2011;108:4099-104 PMCID:PMC3054016

[145] Peterson SC,Vagnozzi AN,Veniaminova NA.Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches..Cell Stem Cell2015;16:400-12 PMCID:PMC4387376

[146] Gutzmer R.Hedgehog pathway inhibition for the treatment of basal cell carcinoma..Target Oncol2019;14:253-67

[147] Duman N,Erol Z.Host immune responses and peritumoral stromal reactions in different basal cell carcinoma subtypes: histopathological comparison of basosquamous carcinoma and high-risk and low-risk basal cell carcinoma subtypes..Turk J Med Sci2016;46:28-34

[148] Zainab H,Shaimaa.Stromal desmoplasia as a possible prognostic indicator in different grades of oral squamous cell carcinoma..J Oral Maxillofac Pathol2019;23:338-43 PMCID:PMC6948064

[149] Kaporis H,Lowes M,Fuentes-Dunclan J.Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment..J Invest Dermatol2007;127:2391-8

[150] Siegel RL,Jemal A.Cancer Statistics..CA Cancer J Clin2017;67:7-30

[151] Skin Cancer Facts & Statistics. 2020. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/. [Last accessed on 7 Sep 2020]

[152] Wells GL. Melanoma - Dermatologic Disorders. Merck Manuals Professional Edition 2019. Available from: https://www.msdmanuals.com/professional/dermatologic-disorders/cancers-of-the-skin/melanoma. [Last accessed on 7 Sep 2020]

[153] Soufir N.Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group..Hum Mol Genet1998;7:209-16

[154] Freedman DM,Rao RS,Alexander B.Risk of melanoma among radiologic technologists in the United States..Int J Cancer2003;103:556-62

[155] Miura K,Rea S,Green AC.Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis..Br J Dermatol2019;181:55-64

[156] Kubica AW.Melanoma in immunosuppressed patients..Mayo Clinic Proceedings2012;87:991-1003 PMCID:PMC3538393

[157] Budden T,Vilain RE,Braye SG.Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair..Oncotarget2016;7:60940-53 PMCID:PMC5308628

[158] Serrano M,Chin L,Beach D.Role of the INK4a locus in tumor suppression and cell mortality..Cell1996;85:27-37

[159] Sharpless E.The INK4a/ARF locus and melanoma..Oncogene2003;22:3092-8

[160] Palmieri G,Colombino M,Sini M.Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets..Front Oncol2015;5:183 PMCID:PMC4530319

[161] Liu J,Li L.Developmental pathways activated in melanocytes and melanoma..Arch Biochem Biophys2014;563:13-21 PMCID:PMC4221383

[162] Cancer Genome Atlas NetworkGenomic classification of cutaneous melanoma..Cell2015;161:1681-96 PMCID:PMC4580370

[163] Curtin JA,Kageshita T,Busam KJ.Distinct sets of genetic alterations in melanoma..N Engl J Med2005;353:2135-47

[164] Lopez-Bergami P,Ronai ZE.Understanding signaling cascades in melanoma..Photochem Photobiol2008;84:289-306 PMCID:PMC2874067

[165] Kunz M.Modelling of protein kinase signaling pathways in melanoma and other cancers..Cancers2019;11:465 PMCID:PMC6520749

[166] Paluncic J,Jansson PJ,Merlot AM.Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling..Biochim Biophys Acta2016;1863:770-84

[167] Orouji E,Gaiser T,Gebhardt C.MAP kinase pathway gene copy alterations inNRAS/BRAFwild-type advanced melanoma..Int J Cancer2016;138:2257-62

[168] Hodis E,Kryukov GV,Imielinski M.A landscape of driver mutations in melanoma..Cell2012;150:251-63 PMCID:PMC3600117

[169] Chen X,Depeille P,Thornton S.RasGRP3 mediates MAPK pathway activation in GNAQ mutant uveal melanoma..Cancer Cell2017;31:685-96.e6 PMCID:PMC5499527

[170] Davies H,Cox C,Edkins S.Mutations of the BRAF gene in human cancer..Nature2002;417:949-54

[171] Broussard L,Ryu S,Norris D.Melanoma cell death mechanisms..Chonnam Med J2018;54:135 PMCID:PMC6165917

[172] Abbaspour Babaei M,Saleem M,Ahmadipour F.Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells..Drug Des Devel Ther2016;10:2443-59 PMCID:PMC4975146

[173] Meng D.KIT as an oncogenic driver in melanoma: an update on clinical development..Am J Clin Dermatol2019;20:315-23

[174] Sakaizawa K,Uchiyama A,Fujisawa Y.Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients..J Dermatol Sci2015;80:33-7

[175] Kong Y,Zhu Y,Corless CL.Large-scale analysis of KIT aberrations in Chinese patients with melanoma..Clin Cancer Res2011;17:1684-91

[176] Avagliano A,Pelagalli A,Ruocco MR.Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment..Front Oncol2020;10:722 PMCID:PMC7256186

[177] Hartman ML.MITF in melanoma: mechanisms behind its expression and activity..Cell Mol Life Sci2015;72:1249-60 PMCID:PMC4363485

[178] Wellbrock C.The complexity of the ERK/MAP-kinase pathway and the treatment of melanoma skin cancer..Front cell dev biol2016;4:33 PMCID:PMC4846800

[179] Buscà R,Gaggioli C,Bille K.Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells..J Cell Biol2005;170:49-59 PMCID:PMC2171372

[180] McGill GG,Widlund HR,Motyckova G.Bcl2 regulation by the melanocyte master regulator mitf modulates lineage survival and melanoma cell viability..Cell2002;109:707-18

[181] Šestáková B,Vachtenheim J.Cell cycle inhibitor p21/WAF1/CIP1 as a cofactor of MITF expression in melanoma cells..Pigment Cell Melanoma Res2010;23:238-51

[182] McKibbin T.Melanoma: understanding relevant molecular pathways as well as available and emerging therapies..Am J Manag Care2015;21:S224-33

[183] Wei SC,Cogdill AP,Anang NAAS.Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade..Cell2017;170:1120-33.e17 PMCID:PMC5591072

[184] Sznol M.Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer..Clin Cancer Res2013;19:1021-34 PMCID:PMC3702373

[185] Zhang N,Zhu G,He H.The association between trauma and melanoma in the Chinese population: a retrospective study..J Eur Acad Dermatol Venereol2013;28:

[186] Möhrle M.Is subungual melanoma related to trauma?.Dermatology2002;204:259-61

[187] Elmore JG,Barnhill RL,Longton GM.Concordance and reproducibility of melanoma staging according to the 7th vs 8th edition of the AJCC cancer staging manual..JAMA Network Open2018;1:e180083 PMCID:PMC6294444

[188] Gastman BR,Kurley SJ,Leachman S.Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria..J Am Acad Dermatol2019;80:149-57.e4

[189] Gerami P,Wilkinson J,Dhillon N.Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma..Clin Cancer Res2015;21:175-83

[190] Gastman BR,Messina JL,Covington KR.Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck..Head Neck2019;41:871-9 PMCID:PMC6667900

[191] Greenhaw BN,Kurley SJ,Cao NA.Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients..J Am Acad Dermatol2020;doi: 10.1016/j.jaad.2020.03.053

[192] Kovarik CL,Adamson AS.Gene expression profile testing for thin melanoma: evidence to support clinical use remains thin..JAMA Dermatol2020;doi: 10.1001/jamadermatol.2020.0894

[193] Dalal M,McCloskey C,Gautam A.The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review..Expert Rev Hematol2020;13:405-19

[194] Bagherani N.An overview of cutaneous T cell lymphomas..F1000Res2016;5:1882 PMCID:PMC4965697

[195] Jahan-Tigh RR,Lee GL,Liu P.Hydrochlorothiazide and cutaneous T cell lymphoma..Cancer2013;119:825-31

[196] Emge DA,Duvic M.Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients..Arch Dermatol Res2020;312:283-8

[197] Pulitzer M.Cutaneous T-cell lymphoma..Clin Lab Med2017;37:527-46 PMCID:PMC5710803

[198] Rasheed H,Gawdat HI,Kamel MM.Serum vitamin D and vitamin D receptor gene polymorphism in mycosis fungoides patients: a case control study..PLoS One2016;11:e0158014 PMCID:PMC4919068

[199] Choi J,Walradt T,Bunick CG.Genomic landscape of cutaneous T cell lymphoma..Nat Genet2015;47:1011-9 PMCID:PMC4552614

[200] Ayhan A,Suryo Rahmanto Y,Ogawa H.Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors..J Pathol Clin Res2015;1:186-93 PMCID:PMC4939882

[201] Yang L,Goodell MA.DNMT3A in haematological malignancies..Nature Reviews Cancer2015;15:152-65 PMCID:PMC5814392

[202] Gallardo F,Díaz-Lagares A,D’Altri T.Notch1 pathway activation results from the epigenetic abrogation of notch-related micrornas in mycosis fungoides..J Invest Dermatol2015;135:3144-52

[203] Dotto GP.Crosstalk of Notch with p53 and p63 in cancer growth control..Nat Rev Cancer2009;9:587-95 PMCID:PMC6059364

[204] Espinosa L,D’Altri T,Statnikov A.The Notch/Hes1 pathway sustains NF-κB Activation through CYLD repression in T cell leukemia..Cancer Cell2010;18:268-81 PMCID:PMC2963042

[205] Manfè V,Rosbjerg A,Skov AG.miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma..PLoS One2012;7:e29541 PMCID:PMC3250447

[206] Walia R.An update on molecular biology of cutaneous T cell lymphoma..Front Oncol2020;9:1558 PMCID:PMC6987372

[207] Wahnschaffe L,Timonen S,Schrader A.JAK/STAT-activating genomic alterations are a hallmark of T-PLL..Cancers2019;11:1833 PMCID:PMC6966610

[208] Rawlings JS,Harrison DA.The JAK/STAT signaling pathway..J Cell Sci2004;117:1281-3 PMCID:PMC6966610

[209] Ungewickell A,Rios E,Lee CS.Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2..Nat Genet2015;47:1056-60 PMCID:PMC6091217

[210] Espinosa L,D’Altri T,Statnikov A.The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia..Cancer Cell2010;18:268-81 PMCID:PMC2963042

[211] Vaqué JP,Monsálvez V,Martínez N.PLCG1 mutations in cutaneous T-cell lymphomas..Blood2014;123:2034-43

[212] Pomerantz JL,Baltimore D.CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex..EMBO J2002;21:5184-94 PMCID:PMC129028

[213] Braun FCM,Möbs M,Eberle J.Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome..Leukemia2011;25:1494-501

[214] McGirt LY,Johnson VE,Zwerner JP.TOX expression and role in CTCL..J Eur Acad Dermatol Venereol2016;30:1497-502 PMCID:PMC4992428

[215] Kremer KN,Sterner RM,Jevremovic D.TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL..Blood2017;130:982-94 PMCID:PMC5570680

[216] Tanase C,Enciu AM,Codrici E.Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches (Review)..Oncol Lett2019;17:4060-7 PMCID:PMC6444338

[217] Liszewski W,Biskup E.Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway..Photodermatol Photoimmunol Photomed2017;33:164-71

[218] Shea L.Brentuximab vedotin in the treatment of peripheral T cell lymphoma and cutaneous T cell lymphoma..Curr Hematol Malig Rep2020;15:9-19

[219] Jawed SI,Horwitz S,Querfeld C.Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part II. Prognosis, management, and future directions..J Am Acad Dermatol2014;70:223.e1-17

[220] Rappaport SM.Environment and disease risks..Science2010;330:460-1 PMCID:PMC4841276

[221] English DR.Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia..Br Med J (Clin Res Ed)1988;296:1285-8 PMCID:PMC2545764

[222] Rizzi A,Sorlini C,Nielsen KM.The stability and degradation of dietary DNA in the gastrointestinal tract of mammals: implications for horizontal gene transfer and the biosafety of GMOs..Crit Rev Food Sci Nutr2012;52:142-61

[223] Potter VR.Initiation and promotion in cancer formation: the importance of studies on intercellular communication..Yale J Biol Med1980;53:367-84 PMCID:PMC2595915

[224] Colon-Echevarria CB,Aquino-Acevedo AN.Neuroendocrine regulation of tumor-associated immune cells..Front Oncol2019;9:1077 PMCID:PMC6828842